Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 526

Similar articles for PubMed (Select 23891824)

1.

Peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms in nonalcoholic fatty liver disease: a study in Brazilian patients.

Domenici FA, Brochado MJ, Martinelli Ade L, Zucoloto S, da Cunha SF, Vannucchi H.

Gene. 2013 Oct 25;529(2):326-31. doi: 10.1016/j.gene.2013.06.091. Epub 2013 Jul 24.

2.

Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control study.

Dongiovanni P, Rametta R, Fracanzani AL, Benedan L, Borroni V, Maggioni P, Maggioni M, Fargion S, Valenti L.

BMC Gastroenterol. 2010 Sep 8;10:102. doi: 10.1186/1471-230X-10-102.

3.

Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus.

Zhang LY, Jin YJ, Jin QS, Lin LY, Zhang DD, Kong LL.

Gene. 2013 Oct 25;529(2):340-4. doi: 10.1016/j.gene.2013.08.001. Epub 2013 Aug 14.

PMID:
23954219
4.

Association between the Pro12Ala polymorphism of PPAR-γ gene and the non-alcoholic fatty liver disease: a meta-analysis.

Wang J, Guo X, Wu P, Song J, Ye C, Yu S, Zhang J, Dong W.

Gene. 2013 Oct 10;528(2):328-34. doi: 10.1016/j.gene.2013.07.014. Epub 2013 Jul 23.

PMID:
23891820
5.

Peroxisome proliferator-activated receptor alpha L162V polymorphism in nonalcoholic steatohepatitis and genotype 1 hepatitis C virus-related liver steatosis.

Verdi H, Koytak ES, Onder O, Ergül AA, Cinar K, Idilman R, Erden E, Bozdayi AM, Yurdaydin C, Uzunalimoglu O, Bozkaya H.

J Investig Med. 2005 Nov;53(7):353-9.

PMID:
16297361
6.

Association of peroxisome proliferator activated receptor-γ gene with non-alcoholic fatty liver disease in Asian Indians residing in north India.

Bhatt SP, Nigam P, Misra A, Guleria R, Luthra K, Pandey RM, Pasha MA.

Gene. 2013 Jan 1;512(1):143-7. doi: 10.1016/j.gene.2012.09.067. Epub 2012 Sep 29.

PMID:
23031808
7.

Influence of polygenetic polymorphisms on the susceptibility to non-alcoholic fatty liver disease of Chinese people.

Zhou YJ, Li YY, Nie YQ, Yang H, Zhan Q, Huang J, Shi SL, Lai XB, Huang HL.

J Gastroenterol Hepatol. 2010 Apr;25(4):772-7. doi: 10.1111/j.1440-1746.2009.06144.x.

PMID:
20492333
8.

Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.

Hsu WH, Chen TH, Lee BH, Hsu YW, Pan TM.

Food Chem Toxicol. 2014 Feb;64:94-103. doi: 10.1016/j.fct.2013.11.015. Epub 2013 Nov 22.

PMID:
24275089
9.

Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease.

Hotta K, Yoneda M, Hyogo H, Ochi H, Mizusawa S, Ueno T, Chayama K, Nakajima A, Nakao K, Sekine A.

BMC Med Genet. 2010 Dec 22;11:172. doi: 10.1186/1471-2350-11-172.

10.

Association between Pro12Ala polymorphism of the PPAR-gamma2 gene and insulin sensitivity in Brazilian patients with type-2 diabetes mellitus.

Tavares V, Hirata RD, Rodrigues AC, Monte O, Salles JE, Scalissi N, Speranza AC, Hirata MH.

Diabetes Obes Metab. 2005 Sep;7(5):605-11.

PMID:
16050954
11.
12.

Effect of peroxisome proliferator-activated receptors-gamma and co-activator-1alpha genetic polymorphisms on plasma adiponectin levels and susceptibility of non-alcoholic fatty liver disease in Chinese people.

Hui Y, Yu-Yuan L, Yu-Qiang N, Wei-Hong S, Yan-Lei D, Xiao-Bo L, Yong-Jian Z.

Liver Int. 2008 Mar;28(3):385-92. Epub 2007 Nov 12. Erratum in: Liver Int. 2008 Feb;28(2):288.

PMID:
17999673
13.

Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 in patients with fatty liver diseases.

Rey JW, Noetel A, Hardt A, Canbay A, Alakus H, Zur Hausen A, Dienes HP, Drebber U, Odenthal M.

World J Gastroenterol. 2010 Dec 14;16(46):5830-7.

14.
15.

Association between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD).

Yoneda M, Hotta K, Nozaki Y, Endo H, Uchiyama T, Mawatari H, Iida H, Kato S, Hosono K, Fujita K, Yoneda K, Takahashi H, Kirikoshi H, Kobayashi N, Inamori M, Abe Y, Kubota K, Saito S, Maeyama S, Wada K, Nakajima A.

BMC Gastroenterol. 2008 Jun 27;8:27. doi: 10.1186/1471-230X-8-27.

16.

Genetic variation in the peroxisome proliferator activated receptor-gamma gene is associated with histologically advanced NAFLD.

Gawrieh S, Marion MC, Komorowski R, Wallace J, Charlton M, Kissebah A, Langefeld CD, Olivier M.

Dig Dis Sci. 2012 Apr;57(4):952-7. doi: 10.1007/s10620-011-1994-2. Epub 2011 Dec 9.

PMID:
22160635
17.
18.

PPARγ2 gene Pro12Ala and PPARα gene Leu162Val single nucleotide polymorphisms interact with dietary intake of fat in determination of plasma lipid concentrations.

Alsaleh A, Frost GS, Griffin BA, Lovegrove JA, Jebb SA, Sanders TA, O'Dell SD; RISCK Study investigators.

J Nutrigenet Nutrigenomics. 2011;4(6):354-66. doi: 10.1159/000336362. Epub 2012 Feb 29.

PMID:
22378291
19.

Association of nonalcoholic fatty liver disease with a single nucleotide polymorphism on the gene encoding leptin receptor.

Swellam M, Hamdy N.

IUBMB Life. 2012 Feb;64(2):180-6. doi: 10.1002/iub.597. Epub 2012 Jan 3.

PMID:
22215535
20.

Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese.

Kawaguchi T, Sumida Y, Umemura A, Matsuo K, Takahashi M, Takamura T, Yasui K, Saibara T, Hashimoto E, Kawanaka M, Watanabe S, Kawata S, Imai Y, Kokubo M, Shima T, Park H, Tanaka H, Tajima K, Yamada R, Matsuda F; Takeshi Okanoue, Japan Study Group of Nonalcoholic Fatty Liver Disease.

PLoS One. 2012;7(6):e38322. doi: 10.1371/journal.pone.0038322. Epub 2012 Jun 14.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk